MEGAN CAMPBELL: Open Payments
NPI 1982162806 · LIBERTY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 37 payments from 12 companies in 2025. Trend: 2023 $175 · 2024 $296 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $164 |
| ABBVIE INC. | 6 | $120 |
| Lilly USA, LLC | 5 | $93 |
| Amgen Inc. | 4 | $58 |
| Astellas Pharma US Inc | 2 | $55 |
| Organogenesis Inc. | 2 | $49 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
Products named: Wegovy, QULIPTA, ZEPBOUND, Veozah, APLIGRAF, UBRELVY, Ozempic, OTEZLA.
Industry payments across MO — which companies pay providers there.
